Is a complete EXEL research report available?

No complete published report is available for Exelixis, Inc. (EXEL) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

EXEL Stock Analysis, Forecast & Valuation

Market cap	14.2B
Revenue (ttm)	2.4B
Net income (ttm)	833.4M
EPS (ttm)	$3.02
Shares out	251.4M
P/E (trailing)	18.5x
P/E (forward)	16.7x
Volume	2,489,458
Beta	0.42

Price target	$52.1	-7.9%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All EXEL indicators

Market & fundamental data

Available fields

277

Groups with data

Currency

USD

Showing 277 of 277 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000939767
Company name	Exelixis, Inc.
Country	United States
Country code	US
Cusip	30161Q104
Employees	1,077
Employees Change	-70%
Employees Change Percent	-6.1
Enterprise value	$12.9B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2000-04-07
Isin	US30161Q1040
Last refreshed	2026-07-29
Market cap	$14.2B
Market cap category	Large-Cap
Price	$56.51
Price currency	USD
Rev Per Employee	2,205,655.52x
Sector	Healthcare
Sector PE	45.6
Sector PE Fwd	24.3
Sic	2836
Symbol	EXEL
Website	https://www.exelixis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.87%
EV Earnings	15.54x
EV Sales Forward	4.84x
EV/EBIT	13.82x
EV/EBITDA	13.41x
EV/FCF	14.11x
EV/Sales	5.45x
FCF yield	6.46%
Forward P/E	16.74x
P/B ratio	7.31x
P/E ratio	18.46x
P/S ratio	5.98x
PE Ratio10 Y	62.12x
PE Ratio3 Y	26.51x
PE Ratio5 Y	28.94x
PEG ratio	1.52x
PS Forward	5.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	39.43%
EBITDA Margin	40.64%
FCF margin	38.63%
Gross margin	96.44%
Gross Profit	$2.3B
Gross Profit Growth	2.98%
Gross Profit Growth Q	10.18%
Gross Profit Growth3 Y	12.6%
Gross Profit Growth5 Y	18.26%
Net Income	$833.4M
Net Income Growth	29.5%
Net Income Growth Q	31.86%
Net Income Growth Quarters	3%
Net Income Growth Years	3%
Net Income Growth3 Y	75.67%
Net Income Growth5 Y	66.69%
Pretax Margin	42.23%
Profit Margin	35.08%
Profit Per Employee	$773,836
Profitable Quarters	$13
Profitable Years	9
ROA	22.03
Roa5y	9.89
ROCE	42.14
ROE	40.99
Roe5y	17.29
ROIC	60.44
Roic5y	29.34

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	20.5%
Cagr15y	14.31%
Cagr1y	23.94%
Cagr20y	9.76%
Cagr3y	42.32%
Cagr5y	27.69%
EPS Growth	37.17
EPS Growth Q	43.64
EPS Growth Quarters	3
EPS Growth Years	3
EPS Growth3 Y	85.92
EPS Growth5 Y	71.26
FCF Growth	11.79%
FCF Growth Q	20.07%
FCF Growth3 Y	51.26%
FCF Growth5 Y	43.37%
OCF Growth	9.74%
OCF Growth Q	19.11%
OCF Growth10 Y	31.39%
OCF Growth3 Y	45.64%
OCF Growth5 Y	36.88%
Revenue Growth	3.33x
Revenue Growth Q	9.97x
Revenue Growth Quarters	3x
Revenue Growth Years	11x
Revenue Growth3 Y	12.6x
Revenue Growth5 Y	18.17x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.87
Assets	$2.6B
Cash	$777.2M
Current Assets	$1.2B
Current Liabilities	$371M
Debt	$169.5M
Debt EBITDA	$0.18
Debt Equity	$0.09
Debt FCF	$0.18
Equity	$1.9B
Liabilities	$657.8M
Long Term Assets	$1.4B
Long Term Liabilities	$286.9M
Net Cash	$1.3B
Net Cash By Market Cap	$8.85
Net Cash Growth	-14.13%
Net Debt EBITDA	$-1.3
Net Debt Equity	$-0.65
Net Debt FCF	$-1.37
Tangible Book Value	$1.9B
Tangible Book Value Per Share	$7.38
WACC	6.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.26
Inventory Turnover	3.28
Net Working Capital	$60.5M
Quick ratio	3.01
Working Capital	$837.7M
Working Capital Turnover	$2.59

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	5.19%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	545.09%
1Y total return	23.93%
200-day SMA	45.54
3Y total return	188.32%
50-day SMA	53.25
50-day SMA vs 200-day SMA	50over200
5Y total return	239.4%
All Time High	57.57
All Time High Change	-1.84%
All Time High Date	2026-07-07
All Time Low	1.26
All Time Low Change	4,384.92%
All Time Low Date	2014-12-23
ATR	1.46
Beta	0.42
Beta1y	0.91
Beta2y	0.88
Ch YTD	28.93
High	56.86
High52	57.57
High52 Date	2026-07-07
High52ch	-1.84%
Low	55.33
Low52	33.76
Low52 Date	2025-10-20
Low52ch	67.41%
Ma50ch	6.12%
Premarket Change Percent	-0.14
Premarket Price	$55.73
Premarket Volume	5,290
Price vs 200-day SMA	24.08%
RSI	60.05
RSI Monthly	73.82
RSI Weekly	74.48
Sharpe ratio	0.65x
Sortino ratio	1.04
Total Return	5.19%
Tr YTD	28.93
Tr15y	643.55%
Tr1m	3.18%
Tr1w	0.69%
Tr3m	26.56%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	19
Analyst Count Top	12
Analyst Price Target Top	$51.64
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$0.84
Earnings EPS Estimate Growth	12
Earnings Revenue Estimate	633,754,384x
Earnings Revenue Estimate Growth	11.52x
Operating Income	$957.2M
Operating Income Growth	17.52
Operating Income Growth Q	34.51
Operating Income Growth3 Y	86.71
Operating Income Growth5 Y	78.62
Operating margin	40.29
Price target	$52.07
Price Target Change	$-7.86
Price Target Change Top	$-8.62

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	204,461,799%
Float Percent	81.34%
Shares Insiders	2.65%
Shares Institutions	89.39%
Shares Out	251,355,083
Shares Qo Q	-3.27%
Shares Yo Y	-5.19%
Short Float	15.12%
Short Ratio	10.75
Short Shares	12.3

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$801.6M
Adjusted OCF	808,572,000
Average Volume	2,304,313.65x
Bv Per Share	7.63
CAPEX	$-7M
Ch10y	545.1
Ch15y	643.6
Ch1m	3.18
Ch1w	0.69
Ch1y	23.93
Ch20y	543.6
Ch3m	26.56
Ch3y	188.3
Ch5y	239.4
Ch6m	29.2
Change	1.25%
Change From Open	0.2
Close	55.81
Days Gap	1.06
Depreciation Amortization	28,658,000
Dollar Volume	140,679,271.6
Earnings Date	2026-08-05
Earnings Time	amc
EBIT	$936.7M
EBITDA	$965.3M
EPS	$3.02
F Score	5
FCF	$917.7M
FCF EV Yield	7.09x
FCF Per Share	$3.65
Financing CF	-1,131,882,000
Fiscal Year End	December
Founded	1,994
Goodwill	63,684,000
Graham Number	22.78044
Graham Upside	-59.69
Income Tax	$169.8M
Investing CF	249,607,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-10
Lynch Fair Value	$75.57
Lynch Upside	33.73
Ma150	47.1
Ma150ch	19.97%
Ma20	55.77
Ma20ch	1.32%
Net CF	42,400,000
Next Earnings Date	2026-08-05
Open	56.4
Optionable	Yes
P FCF Ratio	15.48
P FCF Ratio SBC	17.72
P OCF Ratio	15.36
P OCF Ratio SBC	17.57
Position In Range	77.12
Post Close	56.51
Postmarket Change Percent	0.25
Postmarket Price	$56.65
Ppne	95,524,000
Pre Close	55.81
Price Date	2026-07-28
Price EBITDA	$14.71
Ptbv Ratio	7.59
Relative Volume	1.08x
Revenue	2,375,491,000x
SBC By Revenue	4.89x
Share Based Comp	116,103,000
Tax By Revenue	7.15x
Tax Rate	16.92%
Tr20y	543.62%
Tr6m	29.2%
Us State	California
Volume	2,489,458
Z Score	12.52

Exelixis, Inc. (EXEL)

Coverage state: Market snapshot only — no published research

Generate the first EXEL analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · EXEL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EXEL indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on EXEL

Frequently asked questions